Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by old_dogon Jan 14, 2021 12:18pm
273 Views
Post# 32297329

RE:Steps forward and still needed

RE:Steps forward and still needed
canon12345 wrote: While Dr. Adams has made some strides since the new VMS 3.0 came out there is one major step the company needs to take to propel the stock to much higher levels. We all know that is a substantial Sales order from one of these hospitals ie: MD Anderson or perhaps the Kings College Hospital in London or other top notch facility. Having Chinese interest in the stock also is interesting as this is also the possibility for a large order from China. Dr. Adams also had the foresite to see the market possibilities in the Veterinary space. Far to early to say how this will go but is still a shrewd move and could lead to a secondary or perhaps far larger market then previously thought for the 3.0. The ground work is actually quite impressive in the past few months but we need that large order and several more if this stock is going to go to the heights some of us here believe it will.    



Completely agree, There are some questions I do have withe the current direction and testing facility. Is the unit being used at the university a free unit and I mean free and scot free. Was it sent to te university with a time frame for use and examination of it's abilities in diagnosing heart issues. What is the time frame...1 month...6 months. Are there any obligations from the university to give public feedback that the company can use as a term of reference when aking presentations to other folks in the Vet world. 


Now don't take the requirement for answers as a downer but they are questions that current shareholders should be asking and in all fairness these are things that should have been identified and addressed on the companies public announcment of this deal.

If VPT was rolling along with nice monthly sales then this would not be an issue but under the current terms it just seem prudent.


Still Long...Still Strong.

old_dog
<< Previous
Bullboard Posts
Next >>